Judge William H. Orrick held the Initial Status Conference for the Juul MDL on Friday, November 8th. Prior to that conference he stated that he had a “sense of urgency in moving this case forward. The allegations are very serious and raise significant public health...
Litigation Update: JUUL News
Juul recently announced the departure of four senior executives, Chief Marketing Officer Craig Brommer, Chief Finance Officer Tim Danaher, Chief Administrative Officer Ashley Gould and Senior Vice President of Advanced Technology David Foster. In addition, Juul will...
Litigation Update: IVC Filter Verdict
Earlier this week a Philadelphia jury awarded Tracy Reed-Brown over $33 million in her IVC filter case against Rex Medical LP. The award included more than $30 million in punitive damages, in addition to compensation for medical expenses and pain and suffering. Ms....
Litigation Update: JUUL Census
On October 25th Judge William Orrick issued Case Management Order No. 1 in the JUUL litigation consolidated in his court in the Northern District of California. The Order relates to an initial census, a concept also adopted by Judge M. Casey Rogers of the Northern...
Litigation Update: Risperdal Verdict
Last week a jury in Philadelphia hit Johnson & Johnson and its Janssen Pharmaceuticals subsidiary with an $8 billion punitive damages verdict in a Risperdal trial. Nicholas Murray’s lawsuit alleged that, after being given Risperdal in 2003 at age nine for symptoms...
Litigation Update: Taxotere Defense Verdict
After a two-week trial in New Orleans, the jury in the first Taxotere bellwether trial delivered a defense verdict. There are approximately 11,000 claims in the multi-district litigation against manufacturer Sanofi Aventis and other defendants alleging the...
Litigation Update: Zantac Contamination
According to a recent FDA announcement, a probable human carcinogen has been found in some ranitidine heartburn medications, including brand name Zantac, and the FDA is investigating the possible source of contamination. The substance is NDMA (N-Nitrosodimethylamine),...
Litigation Update: New CEO and New Bans for JUUL
Amid an increasing number of reports of vaping-related illnesses and deaths, Juul announced that Kevin Burns has stepped down as CEO and will be replaced by K.C. Crosthwaite, a former executive at Altria, which owns a 35% stake in Juul, who has previously served as an...
Litigation Update: The Latest on Opioids
There have been a number of developments in the wake of last week’s tentative settlement of over 2,000 lawsuits filed by a number of municipal governments and states in federal court in Cleveland against a number of defendants, including Purdue Pharma and its owners,...
Litigation Update: FDA Takes Action on JUUL Labs
Every day seems to bring new developments in the Juul story, with none of them good for Juul. On September 9, the U.S. Food and Drug administration issued a warning letter to Kevin Burns, the CEO of e-cigarette manufacturer JUUL Labs, Inc., for allegedly marketing the...